Difference between revisions of "EBMonFHIR"
(26 intermediate revisions by the same user not shown) | |||
Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
Return to [[Clinical_Decision_Support_Workgroup|Clinical Decision Support Work Group]] | Return to [[Clinical_Decision_Support_Workgroup|Clinical Decision Support Work Group]] | ||
+ | |||
+ | === '''We migrated from this wiki page to [https://confluence.hl7.org/display/CDS/EBMonFHIR the Confluence page] on May 1, 2019.''' === | ||
The Fast Healthcare Interoperability Resources (FHIR) Resources for Evidence-Based Medicine (EBM) Knowledge Assets project (EBMonFHIR) was approved on May 16, 2018 as an HL7 project. | The Fast Healthcare Interoperability Resources (FHIR) Resources for Evidence-Based Medicine (EBM) Knowledge Assets project (EBMonFHIR) was approved on May 16, 2018 as an HL7 project. | ||
Line 10: | Line 12: | ||
This page will be updated soon with details about how to get involved and stay informed. In the meantime if you want to get involved and stay informed email balper@ebsco.com | This page will be updated soon with details about how to get involved and stay informed. In the meantime if you want to get involved and stay informed email balper@ebsco.com | ||
− | The first [http://wiki.hl7.org/index.php?title=201809_EBMonFHIR EBMonFHIR track] was held at the FHIR Connectathon on September 29-30 | + | The first [http://wiki.hl7.org/index.php?title=201809_EBMonFHIR EBMonFHIR track] was held at the FHIR Connectathon on September 29-30, 2018. The second [http://wiki.hl7.org/index.php?title=201901_EBMonFHIR EBMonFHIR Connectathon track] was held January 12-13, 2019. The next EBMonFHIR Connectathon track will be held on May 4-5, 2019 in Montreal. |
− | |||
==Introduction == | ==Introduction == | ||
− | + | * [https://drive.google.com/open?id=1dFPxFURbnVChPbbovPEs-yJdSmZPG2qX Video 1 - Introduction to FHIR and Evidence Based Medicine] [7 minutes] | |
− | * [https://drive.google.com/open?id=1dFPxFURbnVChPbbovPEs-yJdSmZPG2qX Video 1 - Introduction to | + | * [https://drive.google.com/open?id=1QdMA_8wBeruosWP2rhQoyk9wZmWIfANj Video 2 - EBMonFHIR and the Statistic resource in detail] [36 minutes] |
− | * [https://drive.google.com/open?id= | ||
− | |||
− | |||
==Meeting Information== | ==Meeting Information== | ||
* We meet twice a week on '''Tuesdays at 4:00pm (ET)''' that's FHIR/Technology-focused and '''Thursdays at 9:00am (ET)''' that's EBM/Research-focused. | * We meet twice a week on '''Tuesdays at 4:00pm (ET)''' that's FHIR/Technology-focused and '''Thursdays at 9:00am (ET)''' that's EBM/Research-focused. | ||
− | * [https://ebscomeetings.webex.com/ebscomeetings/j.php?MTID=m6a6f6231678aa5f83c90a661fc2de6e3 Tuesday's | + | * [https://ebscomeetings.webex.com/ebscomeetings/j.php?MTID=m6a6f6231678aa5f83c90a661fc2de6e3 Tuesday's Webex Meeting] and [https://ebscomeetings.webex.com/ebscomeetings/j.php?MTID=mb89d82d9dba170130ee3d5aa2473c85f Thursday's Webex Meeting] |
* Password: '''EBMonFHIR''' | * Password: '''EBMonFHIR''' | ||
<!-- ==== Call Coordinates ==== --> | <!-- ==== Call Coordinates ==== --> | ||
Line 34: | Line 32: | ||
==Project Documents== | ==Project Documents== | ||
− | * [https://docs.google.com/document/d/16j1dIUU4PmXqqOgamy44bxIPyO-WVTXQLaq0oy2PakA/ Introduction to EBMonFHIR] | + | * [https://docs.google.com/document/d/16j1dIUU4PmXqqOgamy44bxIPyO-WVTXQLaq0oy2PakA/ Introduction to EBMonFHIR Document] |
* We decided on April 2, 2019 we created the Statistic resource that replaces the Evidence resource where it has all the same elements but they are no longer nested. At some point we have to create a bundle of related Statistic resources, and the "name" Evidence resource may become a specification for that bundle. | * We decided on April 2, 2019 we created the Statistic resource that replaces the Evidence resource where it has all the same elements but they are no longer nested. At some point we have to create a bundle of related Statistic resources, and the "name" Evidence resource may become a specification for that bundle. | ||
− | * [https://khalid-shahin.github.io/JSON-Tree-Writer/JSON_Tree_Writer-EBMonFHIR-Statistic-Resource.html JSON Tree View of Statistic | + | * [https://drive.google.com/open?id=1UjgVWdN6gTLIX5RndZfkwUQyGwSstMjA EBMonFHIR Google Drive] |
+ | * [https://khalid-shahin.github.io/JSON-Tree-Writer/JSON_Tree_Writer-EBMonFHIR-Statistic-Resource.html JSON Tree View of Statistic] | ||
* [https://ebmonfhirv2.clinicalprofiles.org/statistic.html Statistic resource FHIR build in ClinicalProfiles] | * [https://ebmonfhirv2.clinicalprofiles.org/statistic.html Statistic resource FHIR build in ClinicalProfiles] | ||
* [https://ebmonfhirv2.clinicalprofiles.org/evidencevariable.html EvidenceVariable resource FHIR build in ClinicalProfiles] | * [https://ebmonfhirv2.clinicalprofiles.org/evidencevariable.html EvidenceVariable resource FHIR build in ClinicalProfiles] | ||
− | * [https:// | + | * [https://www.hl7.org/fhir/group.html Group resource in FHIR] |
− | |||
====== Blank Resources (Templates) ====== | ====== Blank Resources (Templates) ====== | ||
Line 50: | Line 48: | ||
* [https://drive.google.com/open?id=1iaBXORIaiL2NPBvtqqs3XB-hGbqY1YFp Artur's Data Table Example] | * [https://drive.google.com/open?id=1iaBXORIaiL2NPBvtqqs3XB-hGbqY1YFp Artur's Data Table Example] | ||
* [http://khalid-shahin.github.io/JSON-Tree-Writer/JSON_Tree_Writer-EBMonFHIR-Statistic_Artur's_Example_01_Comparative.html Artur's Statistic Example 01 - (Comparative Statistic)] and in [https://drive.google.com/open?id=1YkJTAhYF4mEPMdlHph-ArNx2JJVZq3dG XML format]. | * [http://khalid-shahin.github.io/JSON-Tree-Writer/JSON_Tree_Writer-EBMonFHIR-Statistic_Artur's_Example_01_Comparative.html Artur's Statistic Example 01 - (Comparative Statistic)] and in [https://drive.google.com/open?id=1YkJTAhYF4mEPMdlHph-ArNx2JJVZq3dG XML format]. | ||
− | * Artur's Group and EvidenceVariable Examples: [https://khalid-shahin.github.io/JSON-Tree-Writer/JSON_Tree_Writer-EBMonFHIR-Group_Artur's_Example-01.html Group "Allergic Rhinitis"], [https://khalid-shahin.github.io/JSON-Tree-Writer/JSON_Tree_Writer-EBMonFHIR-Group_Artur's_Example-02.html Group "Sublingual Immunotherapy"], [https://khalid-shahin.github.io/JSON-Tree-Writer/JSON_Tree_Writer-EBMonFHIR-Group_Artur's_Example-03.html Group "No Sublingual Immunotherapy"], [https://khalid-shahin.github.io/JSON-Tree-Writer/JSON_Tree_Writer-EBMonFHIR-EvidenceVariable_Artur's_Example-01.html EvidenceVariable "Quality of Life"], [https://khalid-shahin.github.io/JSON-Tree-Writer/JSON_Tree_Writer-EBMonFHIR-EvidenceVariable_Artur's_Example-02.html EvidenceVariable "Withdrawal due to adverse effect"] | + | * Artur's Group and EvidenceVariable Examples (Will be re-worked): [https://khalid-shahin.github.io/JSON-Tree-Writer/JSON_Tree_Writer-EBMonFHIR-Group_Artur's_Example-01.html Group "Allergic Rhinitis"], [https://khalid-shahin.github.io/JSON-Tree-Writer/JSON_Tree_Writer-EBMonFHIR-Group_Artur's_Example-02.html Group "Sublingual Immunotherapy"], [https://khalid-shahin.github.io/JSON-Tree-Writer/JSON_Tree_Writer-EBMonFHIR-Group_Artur's_Example-03.html Group "No Sublingual Immunotherapy"], [https://khalid-shahin.github.io/JSON-Tree-Writer/JSON_Tree_Writer-EBMonFHIR-EvidenceVariable_Artur's_Example-01.html EvidenceVariable "Quality of Life"], [https://khalid-shahin.github.io/JSON-Tree-Writer/JSON_Tree_Writer-EBMonFHIR-EvidenceVariable_Artur's_Example-02.html EvidenceVariable "Withdrawal due to adverse effect"] |
====== Linn's Data Example using Outcomes from Patients with Sepsis using Corticosteroids ====== | ====== Linn's Data Example using Outcomes from Patients with Sepsis using Corticosteroids ====== | ||
Line 66: | Line 64: | ||
<!-- ==== Agendas ==== | <!-- ==== Agendas ==== | ||
*--> | *--> | ||
− | |||
==== Conference Call Recordings and Repository ==== | ==== Conference Call Recordings and Repository ==== | ||
* [https://drive.google.com/open?id=1eo-nptW-8qEAqNXtu8U-S3Pt_TM0EHhuW-th4t60XJA 2018-05-21] | * [https://drive.google.com/open?id=1eo-nptW-8qEAqNXtu8U-S3Pt_TM0EHhuW-th4t60XJA 2018-05-21] | ||
Line 112: | Line 109: | ||
* [https://drive.google.com/open?id=1dF-SMqzyqSDkLjwR93SOlbaOSGJWgMx_9L71yQ4_N2s 2019-03-22 Notes] [https://ebscomeetings.webex.com/ebscomeetings/lsr.php?RCID=1c29a8acbf9244a891bcef0661d86ea3 Video Recording] | * [https://drive.google.com/open?id=1dF-SMqzyqSDkLjwR93SOlbaOSGJWgMx_9L71yQ4_N2s 2019-03-22 Notes] [https://ebscomeetings.webex.com/ebscomeetings/lsr.php?RCID=1c29a8acbf9244a891bcef0661d86ea3 Video Recording] | ||
* [https://drive.google.com/open?id=1hrEAW4DQxcBCzPCNuP7GcA3RtlkFM-nsNOAYJtOQOLI 2019-03-26 Notes] [https://ebscomeetings.webex.com/ebscomeetings/lsr.php?RCID=64f2eb985ea348e984850b3a666e4364 Video Recording] | * [https://drive.google.com/open?id=1hrEAW4DQxcBCzPCNuP7GcA3RtlkFM-nsNOAYJtOQOLI 2019-03-26 Notes] [https://ebscomeetings.webex.com/ebscomeetings/lsr.php?RCID=64f2eb985ea348e984850b3a666e4364 Video Recording] | ||
− | * [https://drive.google.com/open?id=1UmLoCv4-WDFoML5e4uC3g4sL4nr1PW-WECoSDnH_C6E 2019-03-28 Notes] [ | + | * [https://drive.google.com/open?id=1UmLoCv4-WDFoML5e4uC3g4sL4nr1PW-WECoSDnH_C6E 2019-03-28 Notes] [https://ebscomeetings.webex.com/ebscomeetings/lsr.php?RCID=82f6c08719bc4f91833b1ec516e806f1 Video Recording] |
* [https://drive.google.com/open?id=1XIw6RDY3wwNMi7gQE8FvrAOx7iBv7E2NYKjEcrNz1JI 2019-04-02 Notes] [https://ebscomeetings.webex.com/ebscomeetings/lsr.php?RCID=351d2ce528a4450d99767e7e2955e25a Video Recording] | * [https://drive.google.com/open?id=1XIw6RDY3wwNMi7gQE8FvrAOx7iBv7E2NYKjEcrNz1JI 2019-04-02 Notes] [https://ebscomeetings.webex.com/ebscomeetings/lsr.php?RCID=351d2ce528a4450d99767e7e2955e25a Video Recording] | ||
* [https://drive.google.com/open?id=1bsZsYKl37ulrcIFDTbGK8_9258yjXcWWofa7KH0a7Ww 2019-04-04 Notes] [https://ebscomeetings.webex.com/ebscomeetings/lsr.php?RCID=f4f8e7d2b9e34fb5b4e612a7c59f482f Video Recording] | * [https://drive.google.com/open?id=1bsZsYKl37ulrcIFDTbGK8_9258yjXcWWofa7KH0a7Ww 2019-04-04 Notes] [https://ebscomeetings.webex.com/ebscomeetings/lsr.php?RCID=f4f8e7d2b9e34fb5b4e612a7c59f482f Video Recording] | ||
Line 121: | Line 118: | ||
* [https://drive.google.com/open?id=1hKng6Z-MRaOx57Q0By4hyZrxMAWIdVVcPAkIz6ghieU 2019-04-23 Notes] [https://ebscomeetings.webex.com/ebscomeetings/lsr.php?RCID=26b9da7b8c2b44a1ba906638b20ebc59 Video Recording] | * [https://drive.google.com/open?id=1hKng6Z-MRaOx57Q0By4hyZrxMAWIdVVcPAkIz6ghieU 2019-04-23 Notes] [https://ebscomeetings.webex.com/ebscomeetings/lsr.php?RCID=26b9da7b8c2b44a1ba906638b20ebc59 Video Recording] | ||
* [https://drive.google.com/open?id=1KY1_ieJVEF7wOyZDPql5fQzbAJfb8MKF_GN3D61s4o8 2019-04-25 Notes] [https://ebscomeetings.webex.com/ebscomeetings/lsr.php?RCID=253ea1dcbfe44f7e92188ba633ba8f48 Video Recording] | * [https://drive.google.com/open?id=1KY1_ieJVEF7wOyZDPql5fQzbAJfb8MKF_GN3D61s4o8 2019-04-25 Notes] [https://ebscomeetings.webex.com/ebscomeetings/lsr.php?RCID=253ea1dcbfe44f7e92188ba633ba8f48 Video Recording] | ||
+ | * [https://drive.google.com/open?id=1Arzq_yGXWJxLGzUOQZpGAbyiMn6U4s5n_ni5c8LNGv0 2019-04-30 Notes] [https://ebscomeetings.webex.com/ebscomeetings/lsr.php?RCID=43d3c71a7adf4782bd830995e52db565 Video Recording] | ||
+ | |||
+ | === '''We migrated from this wiki page to [https://confluence.hl7.org/display/CDS/EBMonFHIR the Confluence page] on May 1, 2019. No new meeting notes will be posted to this wiki page.''' === | ||
==Status== | ==Status== | ||
The CDS, CQI, and BRR WGs and FHIR management group approved the draft PSS in May of 2018. The next step will be the connectathon in May 2019. | The CDS, CQI, and BRR WGs and FHIR management group approved the draft PSS in May of 2018. The next step will be the connectathon in May 2019. |
Latest revision as of 13:31, 2 May 2019
Return to Clinical Decision Support Work Group
We migrated from this wiki page to the Confluence page on May 1, 2019.
The Fast Healthcare Interoperability Resources (FHIR) Resources for Evidence-Based Medicine (EBM) Knowledge Assets project (EBMonFHIR) was approved on May 16, 2018 as an HL7 project.
EBMonFHIR is sponsored by the Clinical Decision Support Work Group and co-sponsored by the Clinical Quality Information Work Group and Biomedical Research and Regulation Work Group.
The goal of EBMonFHIR is to provide interoperability (standards for data exchange) for those producing, analyzing, synthesizing, disseminating and implementing clinical research (evidence) and recommendations for clinical care (clinical practice guidelines).
This page will be updated soon with details about how to get involved and stay informed. In the meantime if you want to get involved and stay informed email balper@ebsco.com
The first EBMonFHIR track was held at the FHIR Connectathon on September 29-30, 2018. The second EBMonFHIR Connectathon track was held January 12-13, 2019. The next EBMonFHIR Connectathon track will be held on May 4-5, 2019 in Montreal.
Introduction
- Video 1 - Introduction to FHIR and Evidence Based Medicine [7 minutes]
- Video 2 - EBMonFHIR and the Statistic resource in detail [36 minutes]
Meeting Information
- We meet twice a week on Tuesdays at 4:00pm (ET) that's FHIR/Technology-focused and Thursdays at 9:00am (ET) that's EBM/Research-focused.
- Tuesday's Webex Meeting and Thursday's Webex Meeting
- Password: EBMonFHIR
Listserv
- Google group mailing list: https://groups.google.com/forum/#!forum/ebmonfhir
Project Documents
- Introduction to EBMonFHIR Document
- We decided on April 2, 2019 we created the Statistic resource that replaces the Evidence resource where it has all the same elements but they are no longer nested. At some point we have to create a bundle of related Statistic resources, and the "name" Evidence resource may become a specification for that bundle.
- EBMonFHIR Google Drive
- JSON Tree View of Statistic
- Statistic resource FHIR build in ClinicalProfiles
- EvidenceVariable resource FHIR build in ClinicalProfiles
- Group resource in FHIR
Blank Resources (Templates)
- Blank Statistic Resource Entry Form
- Blank Group Resource Entry Form
- Blank EvidenceVariable Resource Entry Form
Artur's Data Example using Sublingual Specific Immunotherapy
- Artur's Data Table Example
- Artur's Statistic Example 01 - (Comparative Statistic) and in XML format.
- Artur's Group and EvidenceVariable Examples (Will be re-worked): Group "Allergic Rhinitis", Group "Sublingual Immunotherapy", Group "No Sublingual Immunotherapy", EvidenceVariable "Quality of Life", EvidenceVariable "Withdrawal due to adverse effect"
Linn's Data Example using Outcomes from Patients with Sepsis using Corticosteroids
Other Examples (Work In Progress)
- Lisa's Data Table Example → Currently in the process of converting to EBMonFHIR JSON
Project Information
Conference Call Recordings and Repository
- 2018-05-21
- 2018-05-24
- 2018-05-29
- 2018-05-31
- 2018-06-05
- 2018-06-11
- 2018-06-18
- 2018-06-28
- 2018-07-05
- 2018-07-12
- 2018-07-19
- 2018-07-26
- 2018-08-02
- 2018-08-09
- 2018-08-16
- 2018-08-23
- 2018-08-30
- 2018-09-06
- 2018-09-20
- 2018-09-27
- 2018-10-12
- 2018-10-19
- 2018-10-26
- 2018-11-02
- 2018-11-09
- 2018-11-16
- 2018-11-23
- 2018-11-30
- 2018-12-07 Notes Video Recording
- 2018-12-14 Notes Video Recording
- 2018-12-21 Notes Video Recording
- 2018-12-28 Notes Video Recording
- 2019-01-04 Notes Video Recording
- 2019-01-11 Notes
- 2019-01-25 Notes Video Recording
- 2019-02-01 Notes Video Recording
- 2019-02-08 Notes Video Recording
- 2019-02-15 Notes Video Recording
- 2019-02-22 Notes Video Recording
- 2019-03-01 Notes Video Recording
- 2019-03-08 Notes Video Recording
- 2019-03-15 Notes Video Recording
- 2019-03-22 Notes Video Recording
- 2019-03-26 Notes Video Recording
- 2019-03-28 Notes Video Recording
- 2019-04-02 Notes Video Recording
- 2019-04-04 Notes Video Recording
- 2019-04-09 Notes Video Recording
- 2019-04-11 Notes Video Recording
- 2019-04-16 Notes Video Recording
- 2019-04-18 Notes Video Recording
- 2019-04-23 Notes Video Recording
- 2019-04-25 Notes Video Recording
- 2019-04-30 Notes Video Recording
We migrated from this wiki page to the Confluence page on May 1, 2019. No new meeting notes will be posted to this wiki page.
Status
The CDS, CQI, and BRR WGs and FHIR management group approved the draft PSS in May of 2018. The next step will be the connectathon in May 2019.